• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Experimental study on blood-inner ear barrier function in MRP1 and p-glycoprotein gene knockout mice

Research Project

Project/Area Number 13671776
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Otorhinolaryngology
Research InstitutionFukui Medical University

Principal Investigator

SAITO Takehisa  Fukui Medical University, Faculty of Medicine, Associate Professor, 医学部, 助教授 (10139769)

Co-Investigator(Kenkyū-buntansha) TSUZUKI Hideaki  Fukui Medical University, University Hospital, Assistant Professor, 医学部附属病院, 講師 (90236927)
柴森 良之  福井医科大学, 医学部・付属病院, 助手 (10303380)
Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2002: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2001: ¥2,300,000 (Direct Cost: ¥2,300,000)
Keywordsp-glycoprotein / MRP1 / mdr1a gene knockout mouse / blood-inner ear barrier / RT-PCR / immunohistochemistry / pharmacokinetics / neurotoxic drugs / mdr 1a遺伝子欠損マウス
Research Abstract

The present study investigated the p-glycoprotein (p-gp) function in the inner ear using mdr1a p-gp gene knock-out mice [mdr1a(-/-) mice] and wild-type mdr1a(+/+) mice. Pharmacokinetic analyses indicated that mdr1a(-/-) mice displayed hypersensitivity to p-gp transported drugs such as doxorubicin (adriamycin) and vinblastine, and increased accumulation of these drugs in the inner ear compared with that in mdr1a(+/+) mice. However, increased accumulation was not detected after administering with ototoxic drug cisplatin, indicating that p-gp had a selectivity for extruding drugs. Electrophysiological studies using auditory brainstem response showed elevated thresholds and prolongations of wave I and wave I to V interpeak latencies only in mdr1a(-/-) mice after administering with doxorubicin or vinblastine alone. Furthermore, inhibition of p-gp function by co-administration with cyclosporin A in mdr1a(+/+) mice resulted in increased accumulation of doxorubicin and vinblastine in the inner … More ear. After pretreatment with cyclosporin A, hearing impairment was detected in mdr1a(+/+) mice treated with doxorubicin or vinblastine alone. From these results, it was suggested that mdr1a p-gp, which acts as an efflux pump, prevented ototoxicity induced by p-gp substrate drugs such as doxorubicin and vinblastine in wild-type mice.
Expression of multidrug resistance protein 1 (MRP1) was detected in the rat cochlea and in the vestibular labyrinth and endolymphatic sac of the guinea pig by immunohistochemical analyses. MRP1 was detected in the lateral wall of the stria vascularis, spiral ligament, spiral prominence and in the cochlear nerve fibers of the modiolus. Furthermore, MRP1 was found in the epithelial lining of the crista ampullaris, utricle, saccule, and epithelial cells of the endolymphatic sac. Since p-gp and MRP1 act as extrusion pumps, they may participate in a bipolar permeation barrier for selected drugs crossing the blood-inner ear barrier resulting in a low concentration of toxic substances and therapeutic drugs in the cochlea, vestibular organs and endolymphatic sac and play an important role in the blood-inner ear barrier. Less

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (22 results)

All Other

All Publications (22 results)

  • [Publications] 斎藤 武久, 他: "内耳における薬剤排出ポンプ(P-糖蛋白とMRP1)の発現とその機能"頭頸部自律神経. 16. 16-20 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Takehisa Saito, et al.: "Expression of multidrug resistance protein 1(MRP1) in the rat cochlea with special reference to the blood-inner ear barrier"Brain Research. 895(1-2). 253-257 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Takehisa Saito, et al.: "Expression of p-glycoprotein is associated with that of multidrug resistance protein 1 (MRP1) in the vestibular labyrinth and endolymphatic sac of the guinea pig"Neuroscience Letters. 303(3). 189-192 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Takehisa Saito, et al.: "Homozygous disruption of the mdr1a p-glycoprotein gene affects blood-nerve barrier function in mice administered with neurotoxic drugs"Acta Otolaryngologica. 121(6). 735-742 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Takehisa Saito, et al.: "Cyclosporin A inhibits the extrusion pump function of p-glysoprotein in the inner ear of mice treated with vinblastine and doxorubicin"Brain Research. 901(1-2). 265-270 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Takehisa Saito, et al.: "Doxorubicin ototoxicity is induced in mice by combination treatment with cyclosporin A"Acta Otolaryngologica. 121(7). 787-793 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Takehisa Saito, et al.: "Expression of multidrug resistance protein 1 (MRP1) in the rat cochlea with special reference to the blood-inner ear barrier"Brain Research. 895(1-2). 253-257 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Takehisa Saito, et al.: "Expression of p-glycoprotein is associated with that of multidrug resistance protein 1 (MRP1) in the vestibular labyrinth and endolymphatic sac of the guinea pig"Neuroscience Letters. 303(3). 189-192 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Takehisa Saito, et al.: "Homozygous disruption of the mdr1a p-glycoprotein gene affects blood-nerve barrier function in mice administered with neurotoxic drugs"Acta Otolaryngologica. 121(6). 735-742 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Takehisa Saito, et al.: "Cyclosporin A inhibits the extrusion pump function of p-glycoprotein in the inner ear of mice treated with vinblastine and doxorubicin"Brain Research. 901(1-2). 265-270 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Takehisa Saito, et al.: "Doxorubicin ototoxicity is induced in mice by combination treatment with cyclosporin A"Acta Otolaryngologica. 121(7). 787-793 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 斎藤 武久, 他: "内耳における薬剤排出ポンプ(P-糖蛋白とMRP1)の発現とその機能"頭頸部自律神経. 16. 16-20 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Takehisa Saito, et al.: "Expression of multidrug resistance protein 1 (MRP1) in the rat cochlea with special reference to the blood-inner ear barrier"Brain Research. 895(1-2). 253-257 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Takehisa Saito, et al.: "Expression of p-glycoprotein is associated with that of multidrug resistance protein 1 (MRP1) in the vestibular labyrinth and endolymphatic sac of the guinea pig"Neuroscience Letters. 303(3). 189-192 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Takehisa Saito, et al.: "Homozygous disruption of the mdr 1a p-glycoprotein gene affects blood-nerve barrier function in mice administered with neurotoxic drugs"Acta Otolaryngologica. 121(6). 735-742 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Takehisa Saito, et al.: "Cyclosporin A inhibits the extrusion pump function of p-glycoprotein in the inner ear of mice treated with vinblastine and doxorubicin"Brain Research. 901(1-2). 265-270 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Takehisa Saito, et al.: "Doxorubicin ototoxicity is induced in mice by combination treatment with cyclosporin A"Acta Otolaryngologica. 121(7). 787-793 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] T.Saito: "Expression of multidrug resistance protein 1(MRP1) in the rat cochlea with special reference to the blood-inner ear barrier"Brain Research. 895(1-2). 253-257 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] T.Saito: "Expression of p-glycoprotein is associated with that of multidrug resistance protein 1(MRP1) in the vestibular labyrinth and endolymphatic sac of the guinea pig"Neuroscience Letters. 303(3). 189-192 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] T.Saito: "Cyclosporin A inhibits the extrusion pump fumction of p-glycoprotein in the inner ear of mice treated with vinblastine and doxorubicin"Brain Research. 901(1-2). 265-270 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] T.Saito: "Homozygous disruption of the mdrla p-glycoprotein gene affects blood-nerve barrier function in mice administered with neurotoxic drugs"Acta Oto-Laryngologica. 121(6). 735-742 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] T.Saito: "Doxorubicin ototoxicity is induced in mice by combination treatment with cyclosporin A"Acta Oto-Laryngologica. 121(7). 787-793 (2001)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi